← Browse by Condition
Medical Condition
head and neck squamous cell carcinoma
Total Trials
16
Recruiting Now
16
Trial Phases
Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for head and neck squamous cell carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — head and neck squamous cell carcinoma Clinical Trials
How many clinical trials are currently recruiting for head and neck squamous cell carcinoma?
ClinicalMetric currently tracks 16 actively recruiting clinical trials for head and neck squamous cell carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 16. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for head and neck squamous cell carcinoma?
head and neck squamous cell carcinoma research spans Phase 1 (8 trials), Phase 2 (5 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a head and neck squamous cell carcinoma clinical trial?
Eligibility criteria for head and neck squamous cell carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 8
Phase 2 5
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05854823
Recruiting
Enrollment
23 pts
Location
China
Sponsor
Fifth Affiliated Hospital, Sun...
NCT05272696 Phase 2
Recruiting
Enrollment
86 pts
Location
China
Sponsor
Guangdong Provincial People's ...
NCT05107674 Phase 1
Recruiting
Enrollment
345 pts
Location
United States, Unite...
Sponsor
Nurix Therapeutics, Inc.
NCT07503808 Phase 1
Recruiting
Enrollment
150 pts
Location
United States
Sponsor
IDEAYA Biosciences
NCT06444815 Phase 1
Recruiting
Enrollment
60 pts
Location
United States
Sponsor
KaliVir Immunotherapeutics
NCT04722523 Phase 1
Recruiting
Enrollment
40 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT06006169 Phase 2
Recruiting
Enrollment
186 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C...
NCT04291105 Phase 2
Recruiting
Enrollment
87 pts
Location
United States, Brazi...
Sponsor
Vyriad, Inc.
NCT05945875 Phase 1
Recruiting
Enrollment
40 pts
Location
United States
Sponsor
Vanderbilt-Ingram Cancer Cente...
NCT06662929
Recruiting
Enrollment
125 pts
Location
Saudi Arabia
Sponsor
King Saud University
NCT04857164 Phase 2
Recruiting
Enrollment
150 pts
Location
China
Sponsor
Yuankai Shi
NCT06999187 Phase 1
Recruiting
Enrollment
96 pts
Location
United States
Sponsor
Dren Bio
NCT06150664 Phase 1
Recruiting
Enrollment
85 pts
Location
United States
Sponsor
Compass Therapeutics
NCT06995508 Phase 2
Recruiting
Enrollment
66 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
NCT05952947 Phase 1
Recruiting
Enrollment
32 pts
Location
China
Sponsor
HRYZ Biotech Co.
NCT04564989
Recruiting
Enrollment
220 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C...
Related Conditions
cervical cancer (4) non small cell lung cancer (4) triple negative breast cancer (3) gastric cancer (2) head and neck cancer (2) ovarian cancer epithelial (1) gastroesophageal junction gej cancer (1) metastatic or unresectable melanoma (1) non small cell lung cancer nsclc (1) metastatic castration resistant prostate cancer mcrpc (1) malignant pleural mesothelioma mpm (1) triple negative breast cancer tnbc (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology